EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,045 | -88.9% | 94,330 | -0.7% | 0.00% | – |
| Q4 2022 | $152,902 | -23.2% | 94,970 | -0.3% | 0.00% | – |
| Q3 2022 | $199,000 | +30.9% | 95,272 | +32.1% | 0.00% | – |
| Q2 2022 | $152,000 | -84.4% | 72,135 | -74.9% | 0.00% | – |
| Q1 2022 | $973,000 | -46.7% | 286,971 | -4.5% | 0.00% | – |
| Q4 2021 | $1,824,000 | -13.1% | 300,436 | +0.8% | 0.00% | – |
| Q3 2021 | $2,100,000 | -52.6% | 298,136 | -7.6% | 0.00% | -100.0% |
| Q2 2021 | $4,433,000 | +62.6% | 322,651 | +26.6% | 0.00% | 0.0% |
| Q1 2021 | $2,727,000 | -1.2% | 254,880 | +11.7% | 0.00% | 0.0% |
| Q4 2020 | $2,759,000 | +134.4% | 228,170 | +2.1% | 0.00% | – |
| Q3 2020 | $1,177,000 | +38.3% | 223,368 | +28.6% | 0.00% | – |
| Q2 2020 | $851,000 | +51.7% | 173,639 | +16.1% | 0.00% | – |
| Q1 2020 | $561,000 | -1.1% | 149,506 | +7.1% | 0.00% | – |
| Q4 2019 | $567,000 | -33.1% | 139,641 | +0.5% | 0.00% | – |
| Q3 2019 | $847,000 | -32.2% | 138,991 | -0.2% | 0.00% | – |
| Q2 2019 | $1,250,000 | +14.1% | 139,200 | +1.6% | 0.00% | – |
| Q1 2019 | $1,096,000 | -34.3% | 136,998 | +6.9% | 0.00% | – |
| Q4 2018 | $1,667,000 | +134.5% | 128,155 | +119.7% | 0.00% | – |
| Q3 2018 | $711,000 | +213.2% | 58,330 | +203.1% | 0.00% | – |
| Q2 2018 | $227,000 | – | 19,247 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 22,577 | $88,502 | 0.17% |